Varex Imaging Co. (NASDAQ:VREX) Shares Bought by Algert Global LLC

Algert Global LLC increased its position in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) by 378.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 169,798 shares of the company's stock after buying an additional 134,338 shares during the quarter. Algert Global LLC owned about 0.41% of Varex Imaging worth $2,477,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Aquatic Capital Management LLC purchased a new position in shares of Varex Imaging in the 4th quarter valued at about $25,000. Quadrant Capital Group LLC grew its position in Varex Imaging by 115.4% during the 4th quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock worth $41,000 after purchasing an additional 1,520 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of Varex Imaging during the fourth quarter worth about $98,000. US Bancorp DE increased its holdings in shares of Varex Imaging by 149.8% in the fourth quarter. US Bancorp DE now owns 7,386 shares of the company's stock valued at $108,000 after purchasing an additional 4,429 shares during the period. Finally, New York State Common Retirement Fund raised its stake in shares of Varex Imaging by 60.7% during the fourth quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock worth $139,000 after purchasing an additional 3,600 shares during the last quarter.

Varex Imaging Price Performance

NASDAQ:VREX traded down $0.09 during trading hours on Tuesday, hitting $7.43. The company's stock had a trading volume of 106,764 shares, compared to its average volume of 498,383. The company has a market capitalization of $306.12 million, a PE ratio of -6.35 and a beta of 0.62. Varex Imaging Co. has a 52-week low of $6.76 and a 52-week high of $16.93. The business's 50-day moving average is $9.76 and its two-hundred day moving average is $12.67. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36.

Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.14 by $0.12. The firm had revenue of $212.90 million during the quarter, compared to analysts' expectations of $206.76 million. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. The firm's quarterly revenue was up 3.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.16 EPS. As a group, research analysts anticipate that Varex Imaging Co. will post 0.53 EPS for the current fiscal year.

Insider Activity

In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now owns 4,002 shares of the company's stock, valued at approximately $51,265.62. This trade represents a 50.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Sunny Sanyal sold 8,749 shares of the business's stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the completion of the sale, the chief executive officer now directly owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. This represents a 4.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on VREX. StockNews.com upgraded shares of Varex Imaging from a "hold" rating to a "buy" rating in a research report on Friday, February 7th. B. Riley raised shares of Varex Imaging to a "strong-buy" rating in a report on Monday. Finally, Oppenheimer cut their price target on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a report on Friday, February 7th.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.